On the sidelines of its 8 th Annual meet, the Pharmaceutical Export Promotion Council of India (Pharmexcil) is organizing an India-Asia-Pacific international meet during 26th-28th September 2012 at Hotel Marriott in Hyderabad.
To leverage India’s pharmaceutical export opportunities in the Asia-Pacific region, the Pharmexcil has invited importers, buyers, FDA and drug regulatory officials from across 12 countries in the Asia Pacific region.
As India’s pharmaceutical exports have been substantially increasing over the years to the Asia-pacific region countries like Australia, Cambodia, Fiji, Indonesia, Laos, Malaysia, Mongolia, Myanmar, New Zealand, Philippines, Thailand and Vietnam, regular interactions with these countries helps improve India’s trade relations on a long term basis.
The council feels that constant networking with major players in these regions will not only give an insight into some of their regulatory aspects for the Indian exporters but it will also help them understand the prevailing market scenario in these countries and accordingly plan strategy to sustain exports or to do possible investments into these countries.
As per the latest statistics for the year 2011, Vietnam stands first among the countries in Asia-Pacific region with a total pharmaceutical import of $144.49 millions from India. Australia stands second with $114.08 million followed by Thailand with $106.48 million.
The other countries to which India exports its drugs and medicines in the region include Philippines, Malaysia and Myanmar which had imported drugs worth $83.35 million, $62.80 million, and $61.84 millions respectively for the year 2011.
In addition to these nations, India is also gradually improving its pharma exports to countries like Fiji, Cambodia, Mongolia and New Zealand in the recent years.
“In view of huge export potential and opportunities available for Indian Pharma to improve our export performance to the Asia-Pacific region we have invited about 60 buyers from different countries in the region to take part in the event. The response is very good and we are expecting about 30 overseas companies to participate in the event,” said Dr Appaji, DG, Pharmexcil.
During the event, technical presentations from FDA and drug regulatory officials of different countries from Asia Pacific region will be presented. These presentations will give an insight into to the various aspects of regulations and prevailing trends in those countries. Members who wish to take part in the mega event can register themselves through Council’s online registration system on or before September 15, 2012.